| 000 | 01777 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514053020.0 | ||
| 264 | 0 | _c20030123 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a1524-4563 | ||
| 024 | 7 |
_a10.1161/01.hyp.0000041882.39865.a8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Xing | |
| 245 | 0 | 0 |
_aIncrease in Cx45 gap junction channels in cerebral smooth muscle cells from SHR. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cDec 2002 |
||
| 300 |
_a940-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta _xcytology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xblood supply |
| 650 | 0 | 4 |
_aCell Line _xcytology |
| 650 | 0 | 4 |
_aCerebral Arteries _xcytology |
| 650 | 0 | 4 |
_aConnexin 43 _xbiosynthesis |
| 650 | 0 | 4 |
_aConnexins _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFemoral Artery _xcytology |
| 650 | 0 | 4 |
_aGap Junctions _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 |
_aQuinine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 | _aRats, Inbred WKY |
| 700 | 1 | _aSimard, J Marc | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 40 _gno. 6 _gp. 940-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.hyp.0000041882.39865.a8 _zAvailable from publisher's website |
| 999 |
_c12273748 _d12273748 |
||